Get started
RocketTickers

Vanda Pharmaceuticals Receives FDA Approval to Proceed with Inve

Long
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)  
RocketTickers  
NASDAQ:VNDA   Vanda Pharmaceuticals Inc.
Beyond Technical Analysis
0
0
beyondta
VNDA: Vanda Pharmaceuticals Inc.
2020-10-26 16:01:00
Vanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New Drug VSJ-110 for Allergic Conjunctivitis
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.